Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: BIOLOGICAL: trastuzumab|DRUG: tipifarnib
Sponsor: National Cancer Institute (NCI)